President Donald Trump signed a “right to try” bill on Wednesday that will allow terminally ill patients to try experimental drugs that haven’t yet been approved by the FDA.
At the ceremony, Trump shared a heartwarming moment with 8-year-old Jordan McLinn, who has Duchenne muscular dystrophy, a condition that slowly weakens muscles and is eventually fatal. The Indianapolis youngster and his family have been advocates for "right to try" legislation.
How will this bill affect patients?
The goal is to let patients who are already dying have access to treatments that haven’t yet made their way through the FDA’s red tape. Terminally ill patients will be able to try drug treatments while they are still in clinical trials.
What did Trump say?
"Thousands of terminally ill Americans will finally have hope, and the fighting chance, and I think it's going to better than a chance, that they will be cured, they will be helped, and be able to be with their families for a long time, or maybe just for a longer time," Trump said of the bill at the signing ceremony.
“The Morning Blaze” take:
On today’s show, Sara and Kris agreed that this bill is a good development, and Sara shared a personal story about a family member who wasn’t allowed to fight for his life with an experimental drug because it didn’t yet have FDA approval. If people know they are dying anyway, shouldn’t we let them try anything that can possibly help?
To see more from Doc, visit his channel on TheBlaze and listen live to “The Morning Blaze with Doc Thompson” weekdays 6 a.m. – 9 a.m. ET, only on TheBlaze Radio Network.
San Diego pastor: 'Drag is holy'